Stem cells provide a unique method for in vitro modeling and screening in a physiologically relevant environment that is both consistent and replicable. Induced pluripotent stem cells (iPSCs), in particular, present a noncontroversial approach for modeling human physiology and disease and for studying the mechanism of action of a drug and its efficacy and safety. However, technical challenges remain to be overcome in culturing and maintaining these cells and a number of researchers remain skeptical about the relevance and validity of results obtained using these cells. Our panel of experts will share their perspectives on the pros and cons of using iPSCs for research and attendees can interact with them during the live webinar by asking questions and sharing their concerns.
Stephen Chang, Ph.D., Vice President of Research and Development, New York Stem Cell Foundation
Hirdesh Uppal, Ph.D., Scientist, Safety Assessment & Development Sciences, Genentech Inc.
Joseph C. Wu, M.D., Ph.D., Director, Stanford Cardiovascular Institute, Professor, Department of Medicine/Cardiology & Radiology, Stanford University School of Medicine